| 000 | 01138 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517202624.0 | ||
| 264 | 0 | _c20190111 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1744-7682 | ||
| 024 | 7 |
_a10.1080/14712598.2018.1445222 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmambux, Sheik | |
| 245 | 0 | 0 |
_aResults and challenges of immune checkpoint inhibitors in colorectal cancer. _h[electronic resource] |
| 260 |
_bExpert opinion on biological therapy _c05 2018 |
||
| 300 |
_a561-573 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xtherapeutic use |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _ximmunology |
| 650 | 0 | 4 |
_aColorectal Neoplasms _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 700 | 1 | _aTachon, Gaelle | |
| 700 | 1 | _aJunca, Audelaure | |
| 700 | 1 | _aTougeron, David | |
| 773 | 0 |
_tExpert opinion on biological therapy _gvol. 18 _gno. 5 _gp. 561-573 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14712598.2018.1445222 _zAvailable from publisher's website |
| 999 |
_c28113483 _d28113483 |
||